Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cleo Diagnostics.
RELATED STOCKHEAD STORIES
Experts
MoneyTalks: Tim Neesham has four ASX picks ready to get the rub of the green
Health & Biotech
ASX Health June Winners: Actinogen and Optiscan led a sector in good shape
Health & Biotech
ASX Health Stocks: Cleo gains FDA momentum for its ovarian cancer detection tech
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX takes a 1pc hit as inflation spooks; IMF bullish on China
News
ASX Small Caps Lunch Wrap: Who’s blasting a leaky Boeing rocket into space next week?
Health & Biotech
ASX Health Stocks: Cleo up 30pc and GTG up 13pc after cancer test kit progress
News
Top 10 at 10: REE-nergised rare earths explorers, biotech standouts lead Wednesday’s winners
Health & Biotech
ASX Health Stocks: CSL’s Phase 3 AEGIS-II trial disappoints, fails to meet primary efficacy endpoint
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Who made American politics even dumber than usual this week?
News
In Case You Missed It: Some of the highest-grade lithium samples ever recorded in Pilbara
Health & Biotech
ASX Health Stocks: PYC on the same page with FDA, Cleo’s cancer test peer-reviewed
News
Closing Bell: ASX has best week ever… or at least since everything crashed last month. So… wait… damn you Friday!
Health & Biotech
ASX Health Stocks: Cleo Diagnostics delivers milestones, Radiopharm to begin Phase 1 study
News
ASX Small Caps and Weekly IPO Wrap: Thanks for the Memory (and the gains) 4DS
IPO Watch
